Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Congruence Therapeutics to Present at Multiple Upcoming Investor Conferences
-
H.B. Fuller Reports First Quarter 2024 Results
-
NeuroPace to Present at the Needham 23rd Annual Healthcare Conference
-
Franklin Covey Reports Second Quarter Fiscal 2024 Financial Results
-
Sprinklr Announces Fourth Quarter and Full Year Fiscal 2024 Results
-
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
WASTE CONNECTIONS ANNOUNCES DATES FOR FIRST QUARTER 2024 EARNINGS RELEASE AND UPCOMING MANAGEMENT PRESENTATIONS
-
Tyson Foods Announces Second Quarter Earnings Conference Call and Webcast
-
The Revolution of Isee Hair’s Glueless Wear and Go Wigs: Redefining Convenience and Comfort
-
Fannie Mae Releases February 2024 Monthly Summary
-
BRIXMOR PROPERTY GROUP ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE AND TELECONFERENCE DATES
-
Grid Dynamics Introduces a GenAI-powered Data Migration Starter Kit to Accelerate Large-Scale Data Modernization Programs
-
RH Reports Fourth Quarter and Fiscal Year 2023 Results
-
MasterBrand Adds Patrick Shannon to Board of Directors
-
Varex Announces Closing of Revolving Credit Facility of $155 Million
-
Century Communities Sets Date for First Quarter 2024 Earnings Release and Conference Call
-
Paycom Wins 2024 Gallup Exceptional Workplace Award
-
Skechers to Report First Quarter 2024 Financial Results on Thursday, April 25th
-
Aqua Metals Advances Sierra-ARC Lithium Battery Recycling Campus and Secures Offtake Partnership; Reports Full-Year 2023 Financial Results
-
American Indian College Fund Invites Indigenous Academics, Administrators, and Student Services Personnel to Participate in Higher Education Listening Sessions April 16 and 22
-
PLBY Group Reports Fourth Quarter & Full Year 2023 Financial Results
-
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
-
Sharecare to report fourth quarter and full year fiscal 2023 financial results on Thursday, March 28
-
Gaia Reports Fourth Quarter and Full Year 2023 Results
-
Zoomcar Partners with ACKO Drive; Empowers Local Hosts to Increase Car Fleet on its Car-Sharing Marketplace Platform
-
Rumble Reports Fourth Quarter and Full Year 2023 Results
-
Axos Financial, Inc. to Announce Third Quarter Fiscal 2024 Results on April 30, 2024
-
Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
-
Lesaka to Host Webcast and Conference Call to Review Third Quarter 2024 Results
-
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
-
RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
Global Investigations Firm Nardello & Co. Expands With Digital Forensics Expert Joseph Pochron
-
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
-
Mulvihill Canadian Bank Enhanced Yield ETF Announces Year End Results
-
S Split Corp. Announces Year End Results
-
World Financial Split Corp. Announces Year End Results
-
Mulvihill Premium Yield Fund Announces Year End Results
-
Mulvihill U.S. Health Care Enhanced Yield ETF Announces Year End Results
-
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
-
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs
-
Usio Announces Record Full Year 2023 Revenues
-
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
-
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
-
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
-
Capital Southwest Receives Affirmed Investment Grade Rating from Fitch Ratings
-
Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat
-
Top 10 Split Trust Announces Year End Results
-
TEAMSTERS' BOYCOTT PRESSURE FORCES MOLSON COORS BACK TO BARGAINING TABLE
